Key facts
- FusionTech (China)’s last known valuation is $39.2M (Jan 2022).
- It has raised $14.9M; the latest was Later Stage VC ($7.0M) in Nov 2025.
- Notable investors include Marathon Venture Partners, Long Hill Capital Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for FusionTech (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for FusionTech (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FusionTech (China)
Developer of a low-code platform designed for various hospital information systems. The company's products cover hospital-wide diagnosis-related groups and diagnosis-intervention packet solutions, smart clinical, smart hospital management and evaluation, the smart medical community, and other core segments, enabling clients to reduce the business system development cost and time to provide easy-to-customize, no-skill-required hospital software with much lower costs to medical institutions and their system integrators.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2015
- Employees
- 150
- Website
- fusiontech.cn/
- Ownership
- Privately Held (backing)
FusionTech (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FusionTech (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FusionTech (China) in its N-PORT filings yet. We sweep new filings monthly.